| Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study A Mooranian, S Raj Wagle, B Kovacevic, R Takechi, J Mamo, V Lam, ... Scientific Reports 10 (1), 106, 2020 | 50 | 2020 |
| Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies SR Wagle, B Kovacevic, D Walker, CM Ionescu, U Shah, G Stojanovic, ... Expert Opinion on Drug Delivery 17 (10), 1361-1376, 2020 | 48 | 2020 |
| Micro-Nano formulation of bile-gut delivery: Rheological, stability and cell survival, basal and maximum respiration studies SR Wagle, D Walker, B Kovacevic, A Gedawy, M Mikov, S Golocorbin-Kon, ... Scientific Reports 10 (1), 7715, 2020 | 37 | 2020 |
| Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 … A Mooranian, N Zamani, R Takechi, H Al-Sallami, M Mikov, ... Artificial cells, nanomedicine, and biotechnology 46 (sup3), 748-754, 2018 | 35 | 2018 |
| Pharmacological and advanced cell respiration effects, enhanced by toxic human-bile nano-pharmaceuticals of probucol cell-targeting formulations SR Wagle, B Kovacevic, D Walker, CM Ionescu, M Jones, G Stojanovic, ... Pharmaceutics 12 (8), 708, 2020 | 33 | 2020 |
| The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications B Kovacevic, M Jones, C Ionescu, D Walker, S Wagle, J Chester, T Foster, ... Biomaterials 283, 121459, 2022 | 29 | 2022 |
| Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and … A Mooranian, N Zamani, CM Ionescu, R Takechi, G Luna, M Mikov, ... Pharmacological Reports 72, 368-378, 2020 | 23 | 2020 |
| A review on recent advancement on age-related hearing loss: the applications of nanotechnology, drug pharmacology, and biotechnology J Chester, E Johnston, D Walker, M Jones, CM Ionescu, SR Wagle, ... Pharmaceutics 13 (7), 1041, 2021 | 22 | 2021 |
| A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds A Mooranian, N Zamani, M Mikov, S Goločorbin-Kon, G Stojanovic, ... Saudi Pharmaceutical Journal 28 (2), 165-171, 2020 | 21 | 2020 |
| Modulatory nano/micro effects of diabetes development on pharmacology of primary and secondary bile acids concentrations A Mooranian, N Zamani, R Takechi, G Luna, M Mikov, S Goločorbin-Kon, ... Current Diabetes Reviews 16 (8), 900-909, 2020 | 20 | 2020 |
| Pharmacological and biological study of microencapsulated probucol-secondary bile acid in a diseased mouse model SR Wagle, B Kovacevic, CM Ionescu, D Walker, M Jones, L Carey, ... Pharmaceutics 13 (8), 1223, 2021 | 19 | 2021 |
| Pharmacological effects of secondary bile acid microparticles in diabetic murine model A Mooranian, N Zamani, B Kovacevic, CM Ionescu, G Luna, M Mikov, ... Current Diabetes Reviews 18 (1), 83-92, 2022 | 17 | 2022 |
| Advancements in assessments of bio-tissue engineering and viable cell delivery matrices using bile acid-based pharmacological biotechnologies A Mooranian, M Jones, CM Ionescu, D Walker, SR Wagle, B Kovacevic, ... Nanomaterials 11 (7), 1861, 2021 | 17 | 2021 |
| Bio micro-nano technologies of antioxidants optimised their pharmacological and cellular effects, ex vivo, in pancreatic β-cells A Mooranian, N Zamani, M Mikov, S Goločorbin-Kon, G Stojanovic, ... Nanotechnology, Science and Applications, 1-9, 2020 | 17 | 2020 |
| Bile acid-polymer-probucol microparticles: Protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model A Mooranian, N Zamani, G Luna, H Al-Sallami, M Mikov, ... Pharmaceutical development and technology 24 (10), 1272-1277, 2019 | 16 | 2019 |
| Formulation buoyancy of nanoencapsulated gliclazide using primary, conjugated and deconjugated bile acids S Mathavan, CM Ionescu, B Kovacevic, M Mikov, S Golocorbin-Kon, ... Therapeutic Delivery 10 (9), 573-583, 2019 | 15 | 2019 |
| Enhanced bilosomal properties resulted in optimum pharmacological effects by increased acidification pathways A Mooranian, T Foster, CM Ionescu, D Walker, M Jones, SR Wagle, ... Pharmaceutics 13 (8), 1184, 2021 | 14 | 2021 |
| Microencapsulation of Coenzyme Q10 and bile acids using ionic gelation vibrational jet flow technology for oral delivery M Jones, D Walker, CM Ionescu, B Kovacevic, SR Wagle, A Mooranian, ... Therapeutic Delivery 11 (12), 791-805, 2020 | 14 | 2020 |
| Histological effects of pharmacologically active human bile acid nano/micro-particles in Type-1 diabetes S Mathavan, CM Ionescu, B Kovacevic, M Mikov, S Golocorbin-Kon, ... Therapeutic Delivery 11 (3), 157-171, 2020 | 14 | 2020 |
| Probucol-poly (meth) acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice A Mooranian, N Zamani, R Takechi, H Al-Sallami, M Mikov, ... Therapeutic Delivery 10 (9), 563-571, 2019 | 14 | 2019 |
Dr Armin MooranianLecturer of Pharmacy and Pharmaceutical Sciences在 curtin.edu.au 的电子邮件经过验证
